News
In a new study, researchers have found that mice can instinctively exhibit rescue-like behavior toward anesthetized ...
Scientists have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.
The Pre-College Program in Computational Biology offers comprehensive training in both state-of-the-art laboratory techniques for generating biological data and the computational methods necessary to ...
In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...
13d
Arabian Post on MSN2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapiesApril 2025 – Together with world-renowned scientists including Prof. Joel F. Habener, Prof. Jens Juul Holst and Assoc. Prof. Svetlana Mojsov, Prof. Daniel Drucker at the University of Toronto and the ...
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...
Glucagon-like peptide 1 (GLP-1) receptor agonists are transforming the treatment landscape for type 2 diabetes ( T2D) and obesity, in addition to their cardiovascular benefits. These drugs also ...
Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to the development of Ozempic-style drugs.
The 2025 Breakthrough Prize in Life Sciences has been awarded to five scientists for the discovery and characterization of the hormone glucagon-like peptide-1 ... mid-1980s — went on to characterize ...
Americans have struggled to afford the blockbuster class of weight loss medications called GLP-1, or glucagon-like peptide-1, receptor agonists. The drugs were first used to treat diabetes but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results